Riskpilot← Back to searchSign inGet full accessNorthlind Medical AB
ABActiveOrg 5593673527Kroppkärrsvägen 45Wholesale of pharmaceutical and medical goods · NACE 4646Est. 20220 employees
Revenue 2025
SEK 1,5M
+71% vs 2024
EBITDA margin
33.4%
+56% vs 2024
Equity ratio
54.5%
Financial strength
Net profit 2025
SEK 398K
+56% vs 2024
| Revenue | SEK 1,5M | +71% |
| EBITDA | SEK 502K | +56% |
| Net profit | SEK 398K | +56% |
| Total assets | SEK 902K | +59% |
| Equity | SEK 492K | +67% |
| Employees | 0 | — |
Legal name
Northlind Medical AB
Org number
5593673527
Legal form
Aktiebolag
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
24 februari 2022
Share capital
SEK 25 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bedriva försäljning och marknadsföring av medicinteknisk utrustning och därtill förenlig verksamhet. Bolaget skall även bedriva konsult- och utbildningsverksamhet inom hälso- och sjukvård liksom management consulting. Äga och förvalta aktier med förenlig verksamhet.
Address
Kroppkärrsvägen 45
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue | 138 | 996 | 878 | 1 505 |
| Staff expenses | — | — | — | −16 |
| EBITDA | 25 | 247 | 321 | 502 |
| Depreciation & amort. | — | — | — | — |
| EBIT | 25 | 247 | 321 | 502 |
| Net financials | — | 0 | 0 | −1 |
| Profit before tax | 25 | 247 | 321 | 501 |
| Tax | −5 | −52 | −67 | −104 |
| Net profit | 20 | 195 | 255 | 398 |
| Item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Total assets | 152 | 395 | 569 | 902 |
| Equity | 45 | 240 | 294 | 492 |
| Long-term debt | — | — | — | — |
| Short-term debt | 107 | 155 | 275 | 410 |
| Total debt | 107 | 155 | 275 | 410 |
EBITDA margin
33.4%
This company
15.8%
Market median
+111% vs market
20222025
Equity ratio
54.5%
This company
38.2%
Market median
+43% vs market
20222025
Return on equity
80.8%
This company
18.4%
Market median
+339% vs market
20222025
Net profit margin
26.4%
This company
8.1%
Market median
+226% vs market
20222025
Asset turnover
1.67×
This company
1.12×
Market median
+49% vs market
20222025
Debt / equity
0.83×
This company
0.62×
Market median
+34% vs market
20222025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-02-24 – 2022-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Deputy Board Member | 2022 | |
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
| Former (4) | ||
| Deputy Board Member | 2022 – 2022 | |
| Board of Directors | 2022 – 2022 | |
| Board of Directors | 2022 – 2022 | |
| Deputy Board Member | 2022 – 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Northlind Medical AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Marianne Terese Lindberg | Deputy Board Member | 0 companies |
| Elene Isakadze | Deputy Board Member | 0 companies |
| Patrik Johannes Lindberg | Deputy Board Member | 0 companies |
| Niklas Christoffer Lindberg | Board of Directors | 0 companies |
| Therese Lilly Felicia Wickström | Board of Directors | 0 companies |
| Yashar Kozubalakov | Board of Directors | 0 companies |
| Ros-Mari Wickström | Deputy Board Member | 0 companies |